Letermovir 240 mg is a revolutionary antiviral medication for preventing Cytomegalovirus (CMV) in high-risk transplant patients, particularly those undergoing hematopoietic stem cell transplantation (HSCT). By inhibiting CMV replication, it reduces serious complications and improves recovery rates. Available through trusted distributors like Impomed Healthcare, this medication Letermovir 240 mg in India is transforming CMV prophylaxis in India. Download the PDF for more details. For more information click on this link-:https://www.impomedhealthcare.com